As Vice President, Pharmaceutical Sciences and Technology, Jean Bender is accountable for leading all CMC activities for Visterra’s product pipeline. Prior to Visterra, Jean led the BioProcess Engineering department at Medimmune LLC where she was responsible for process development engineering, scale-up and transfer of drug substance processes. Previously she held roles of increasing responsibility within Genentech Inc., where she was responsible for tech transfer and licensure of monoclonal antibody processes within the Genentech/Roche manufacturing network.
Jean has a MS in Chemical Engineering from UC Berkeley and a BS in Chemical Engineering from Lehigh University.
